4
Changes in Ownership
10x Genomics, Inc. Filed Acc 0001209191-21-007564
Director sold 7,500 shares at an average $176.05 ($1,320,380)
From the SEC's structured data for this filing
Trades in this filing
STUELPNAGEL JOHN R · Director
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-02-01 | Sale : show line 1 in the form | −400 | $174.14 | $69,656 | 473,091 | D |
| 2021-02-01 | Sale : show line 2 in the form | −3,094 | $175.38 | $542,624 | 469,997 | D |
| 2021-02-01 | Sale : show line 3 in the form | −2,304 | $176.14 | $405,821 | 467,693 | D |
| 2021-02-01 | Sale : show line 4 in the form | −1,202 | $177.23 | $213,035 | 466,491 | D |
| 2021-02-01 | Sale : show line 5 in the form | −300 | $178.16 | $53,447 | 466,191 | D |
| 2021-02-01 | Sale : show line 6 in the form | −200 | $178.98 | $35,796 | 465,991 | D |
| Open-market sales · 7,500 sh · avg $176.05 · $1,320,380 | ||||||
Loading xslF345X03/doc4.xml…